相似文献
1
Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment.
Front Cardiovasc Med. 2018 Sep 4;5:121. doi: 10.3389/fcvm.2018.00121. eCollection 2018.
2
[Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
Rev Esp Anestesiol Reanim. 2014 May;61(5):246-53. doi: 10.1016/j.redar.2013.11.015. Epub 2014 Feb 5.
3
Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
World J Pediatr Congenit Heart Surg. 2014 Oct;5(4):515-21. doi: 10.1177/2150135114549748.
4
Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance.
J Card Surg. 2000 Sep-Oct;15(5):347-53. doi: 10.1111/j.1540-8191.2000.tb00470.x.
5
A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.
Anesth Analg. 2018 Sep;127(3):678-687. doi: 10.1213/ANE.0000000000002837.
6
Risk assessment and outcomes of vasoplegia after cardiac surgery.
Gen Thorac Cardiovasc Surg. 2017 Oct;65(10):557-565. doi: 10.1007/s11748-017-0789-6. Epub 2017 Jun 13.
7
Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
Clin Appl Thromb Hemost. 2018 Nov;24(8):1322-1326. doi: 10.1177/1076029618772357. Epub 2018 May 6.
8
Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3080-3084. doi: 10.1053/j.jvca.2019.03.004. Epub 2019 Mar 8.
9
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.
Eur J Cardiothorac Surg. 2007 May;31(5):817-20. doi: 10.1016/j.ejcts.2007.02.010. Epub 2007 Mar 12.
10
Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022. doi: 10.1053/j.jvca.2017.10.032. Epub 2017 Oct 27.
引用本文的文献
1
Retrospective Review of Intraoperative Hypotension and Perioperative Angiotensin Inhibitor Use in Pediatrics.
Paediatr Anaesth. 2025 Oct;35(10):848-855. doi: 10.1111/pan.70004. Epub 2025 Jun 27.
本文引用的文献
1
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.
Eur J Cardiothorac Surg. 2018 Jan 1;53(1):5-33. doi: 10.1093/ejcts/ezx314.
2
Angiotensin II for the Treatment of Vasodilatory Shock.
N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21.
3
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.
Anesthesiology. 2017 Jan;126(1):16-27. doi: 10.1097/ALN.0000000000001404.
4
Con: ACE Inhibitors Should Be Stopped Prior to Cardiovascular Surgery.
J Cardiothorac Vasc Anesth. 2016 Jun;30(3):820-2. doi: 10.1053/j.jvca.2016.01.016. Epub 2016 Jan 12.
5
The Use and Misuse of ACE Inhibitors in Patients with Single Ventricle Physiology.
Heart Lung Circ. 2016 Mar;25(3):229-36. doi: 10.1016/j.hlc.2015.10.005. Epub 2015 Oct 27.
6
Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
World J Pediatr Congenit Heart Surg. 2014 Oct;5(4):515-21. doi: 10.1177/2150135114549748.
7
Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years.
J Clin Hypertens (Greenwich). 2008 Oct;10(10):743-50. doi: 10.1111/j.1751-7176.2008.00022.x.
8
Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertension.
J Hum Hypertens. 2009 Jun;23(6):420-5. doi: 10.1038/jhh.2008.139. Epub 2008 Dec 4.
9
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
N Engl J Med. 2008 Jun 26;358(26):2787-95. doi: 10.1056/NEJMoa0706585.
10
Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
J Hum Hypertens. 1997 Sep;11 Suppl 2:S37-42.
Zotero 插件